Virpax Pharmaceuticals, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Virpax Pharmaceuticals, Inc..

News

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update

Zolmax Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX - Get Free Report) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totalling 268,400...\n more…

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Sees Large Decline in Short Interest

Ticker Report Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX - Get Free Report) saw a large decrease in short interest during the month of July. As of July 31st, there was short interest totalling 268,400 shares, a...\n more…

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

Business Wire Virpax Pharmaceuticals, Inc. (Virpax or the Company) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...\n more…

VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nVirpax Pharmaceuticals just reported results for the second quarter of 2024.\nThe post VRPX Stock Earnings: Virpax Pharmaceuticals...\n more…

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

Virpax Pharmaceuticals files to sell common stock and warrants, no amount given

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…